Evaluation of the efficacy and safety of QMF149 vs Mometasone in patients with asthma

Update Il y a 4 ans
Reference: EUCTR2015-002529-21

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To demonstrate the superiority of either QMF149 150/160 μg delivered via Concept1 o.d. (in the evening) to MF 400 μg o.d (in the evening) delivered via Twisthaler® or QMF149 150/320 μg delivered via Concept1 o.d. (in the evening) to MF 800 μg delivered via Twisthaler® (delivered as 400 μg b.i.d.) in terms of FEV1 at 26 weeks.


Inclusion criteria

  • Asthma